PHARMA BOARDROOM – Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry
19 October 2022
Victor Mendonça, chair of the Generic Market Access Committee at Medicines for Europe, outlines why patient access to medicines is at risk due to intense price pressure and unprecedented inflation and proposes ways to tackle this.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
